Immunovant, Inc

Founded in 1982, PAREXEL International is a biopharmaceutical services organization that provides a range of knowledge-based contract research and medical communications services. It operates in more than 50 countries and employs over 7,300 individuals. The organization serves the pharmaceutical, biotechnology and medical device industries. PAREXEL International offers drug development and regulatory consulting services. The company provides clinical pharmacology and trials management, medical education and reimbursement services. Its subsidiary, Perceptive Informatics offers advanced technology solutions, including medical imaging to facilitate the clinical development processes. The company s medical writing services group compiles, organizes, writes, edits and produces medical and scientific documentation. In addition, it provides communications and publications planning services. PAREXEL International maintains a location in Durham, N.C.

Adherex Technologies is a biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics. Its mission is to become an industry leader in addressing the unmet medical needs of cancer patients. The company currently has multiple oncology products in the clinical stage of development including eniluracil, ADH-1, and sodium thiosulfate (STS). Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, was previously under development by GlaxoSmithKline for oncology indications. Adherex is developing eniluracil to improve the therapeutic value and effectiveness of 5-fluorouracil (5-FU), one of the most widely used oncology drugs in the world. Adherex also has a rich preclinical portfolio based on its proprietary cadherin platform. This pipeline includes peptides and small chemical molecule successors to ADH-1; peptides and small molecules targeted to inhibiting the metastatic spread of some cancers; and peptides that combine both angiolytic and antiangiogenic properties. With a diversified portfolio of unique clinical-stage and preclinical cancer compounds and a management team with expertise in identifying, developing and commercializing novel cancer therapeutics, Adherex is emerging as a pioneering oncology company.

Worldwide Clinical Trials is a global contract research organization (CRO) that specializes in providing tailored clinical solutions for the pharmaceutical and biotechnology industries. With over 30 years of experience, their team of experts offers a wide range of services, including bioanalytical lab capabilities, clinical trials, real-world evidence studies, and expertise in various therapeutic areas such as oncology, neurology, and rare diseases. They pride themselves on their personalized approach, working closely with clients to meet their specific goals and navigate the complex landscape of clinical research. Committed to therapeutic excellence and personalized attention, Worldwide Clinical Trials offers flexible and responsive solutions backed by decades of therapeutically relevant expertise. They understand that every study is unique and strive to provide customized solutions that are tailored to each client's specific needs. With a global reach and a team of dedicated professionals, they are dedicated to bringing clarity to complex drug development and helping clients achieve success in their clinical trials.Generated from the website